Displaying 25 - 32 of 32

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Displaying 25 - 32 of 32

Display:

12 24 48